News Sentiment

DMII sentiment intelligence

Drugs Made In America Acquisition II Corp. Ordinary Shares news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 47 Balanced news tone 44 relevant articles
Exchange NASDAQ United States
Sector Financial Services Market context
Industry Shell Companies Read-through group
Latest close 10.10 Week of 10 Jul 2026
Weighted tone 47/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Deals and strategy

87/100 classification confidence.

Company focus 44

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

+0.1% over one week, +0.2% over four weeks, trend active, and near fair-value range.

Latest direct headline Neutral

Drugs Made In America Acquisition (NASDAQ:DMAA) Trading Down 0.1% - Here's What Happened

Market Reaction

Balanced read

54/100 confidence

News tone and price action are not far from neutral.

Primary event Deals and strategy 87/100 classification
One-week reaction 0.1% Price digesting
Trend fit Trend active 0.2% over four weeks
Fair value 1.1% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 3
Neutral 33
Negative 8

Relevance

Why the article matched

Direct first
Direct company coverage 44
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 11
TradingView 7
Meyka 4
MarketBeat 2
www.marketscreener.com 2
Investing.com 2
TipRanks 2
Market source 2

Event Lens

What the news is about

Classified themes
Deals and strategy 34
Market update 9
Earnings 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-44 of 44
Stock Titan Direct company coverage

Drugs Made In America II (NASDAQ: DMII) plans $1.4M convertible note funding

Drugs Made In America Acquisition II Corp. (NASDAQ: DMII) has entered into an agreement for up to $1.4 million in convertible note funding with Alpha Multi Family Office. The initial tranche involved an unsecured, zero-interest Bridge Note for $150,000, convertible at a 35% disco

Tone
Neutral 50/100
Event
Deals and strategy
Published
18 Mar 2026 03:09
Source
Stock Titan
TradingView Direct company coverage

Drugs Made In America Acquisition II Secures $150,000 Convertible Bridge Note From Alpha Multi Family Office

Drugs Made In America Acquisition II (DMII) has secured a $150,000 unsecured convertible bridge note from Alpha Multi Family Office to cover near-term transaction costs. The nine-month, zero-interest note can convert into post-combination company shares at a 35% discount upon bus

Tone
Neutral 50/100
Event
Deals and strategy
Published
17 Mar 2026 20:09
Source
TradingView
Meyka Direct company coverage

DMIIR - AI Stock Analysis

This article provides an AI-powered stock analysis for Drugs Made In America Acquisition II Corp. Right (DMIIR). The AI model gives DMIIR an overall forecast score of 51/100 (C+), indicating normal performance with weak confidence in its potential. While its financial and fundame

Tone
Neutral 50/100
Event
Deals and strategy
Published
16 Mar 2026 03:39
Source
Meyka
Investing.com Direct company coverage

Drugs Made In America Acquisition II Corp. appoints new CEO after sponsor repayment issue

Drugs Made In America Acquisition II Corp. (NASDAQ:DMIIU) has appointed Roger Bendelac as its new CEO, following the resignation of Lynn Stockwell. Stockwell's resignation was requested after the company discovered its sponsor had over-withdrawn funds from the working capital acc

Tone
Neutral 50/100
Event
Deals and strategy
Published
08 Mar 2026 22:51
Source
Investing.com
Stock Titan Direct company coverage

CEO exits Drugs Made In America (NASDAQ: DMAA) after affiliate fund withdrawals

Drugs Made In America Acquisition Corp. (DMAA) announced the resignation of CEO Lynn Stockwell and the appointment of Roger Bendelac following financial discrepancies involving an affiliated SPAC's working capital account. The affiliate's sponsor withdrew $1,100,000 and had an ov

Tone
Neutral 50/100
Event
Deals and strategy
Published
08 Mar 2026 22:51
Source
Stock Titan
Stock Titan Direct company coverage

Sponsor overpayment leads to CEO change at Drugs Made In America II (DMII)

Drugs Made In America Acquisition II Corp. (DMII) experienced a significant leadership change due to a sponsor overpayment issue. The sponsor withdrew $1,100,000 from the company's working capital, with a substantial portion ($566,269 plus at least $200,000) identified as an over

Tone
Negative 13/100
Event
Deals and strategy
Published
07 Mar 2026 21:52
Source
Stock Titan
ChartMill Direct company coverage

DMIIR Stock Price, Quote & Chart | DRUGS MADE IN AMERICA ACQ-RT (NASDAQ:DMIIR)

DRUGS MADE IN AMERICA ACQ-RT (NASDAQ:DMIIR) shares closed at $0.09, down 18.18% today, and are trading at $0.13 after hours, up 44.44%. The company, a blank check company focused on the pharmaceutical industry, has seen its stock decline by 25% over the past month. ChartMill assi

Tone
Neutral 50/100
Event
Market update
Published
07 Mar 2026 21:51
Source
ChartMill